TGI of humanized models to atezolizumab
| Model | TGI (%) |
| H1975 | 8 |
| H1299 | 33 |
| A375 | 47 |
| A549 | −4 |
| HCT116 | 15 |
| RKO | 31 |
| KU-19–19 | 0 |
| Caki-1 | 31 |
| HCC827 | 56 |
| MDA-MB-231 | 52 |
TGI following anti-PD-L1 treatment was calculated according to the Materials and methods section.
PD-L1, programmed death ligand 1; TGI, tumor growth inhibition.